SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042461
Filing Date
2021-08-13
Accepted
2021-08-13 16:01:41
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_longeveron.htm   iXBRL 10-Q 966025
2 CERTIFICATION f10q0621ex31-1_longeveron.htm EX-31.1 17807
3 CERTIFICATION f10q0621ex31-2_longeveron.htm EX-31.2 17025
4 CERTIFICATION f10q0621ex32-1_longeveron.htm EX-32.1 8473
  Complete submission text file 0001213900-21-042461.txt   4742466

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lgvn-20210630.xsd EX-101.SCH 53792
6 XBRL CALCULATION FILE lgvn-20210630_cal.xml EX-101.CAL 37966
7 XBRL DEFINITION FILE lgvn-20210630_def.xml EX-101.DEF 251061
8 XBRL LABEL FILE lgvn-20210630_lab.xml EX-101.LAB 456132
9 XBRL PRESENTATION FILE lgvn-20210630_pre.xml EX-101.PRE 260018
10 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_longeveron_htm.xml XML 469692
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Filer) CIK: 0001721484 (see all company filings)

IRS No.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40060 | Film No.: 211171986
SIC: 2834 Pharmaceutical Preparations